
Overview
Legality, rules text, flavor, and catalog metadata from the import
Rules
自分の山札から進化ポケモンとエネルギーを1枚ずつ選び、相手に見せて、手札に加える。そして山札を切る。 サポートは、自分の番に1枚しか使えない。
Catalog metadata
- National Pokédex
- 0
- Imported from
- Vendor Tools Public API catalog
Card details
Identity, type line, stats, and set references
Identity & printing
- Name
- Hildaトウコ
- Number
- 85
- Printed number
- 085/086
- Rarity
- 非 (Uncommon)
- Variant
- Poke Ball Reverse Holofoil
- Language code
- JA
- Print ID
- sv11w_ja-85-Poke-Ball-Reverse-Holofoil
Type line & stats
- Supertype
- トレーナー (Trainer)
- Subtypes
- 支援 (Supporter)
- Types
- Unknown
Set, artist & references
- Artist
- yuu
- Language
- Japanese
- Set name
- ホワイトフレア (White Flare)
- Game name
- Pokémon Japan
Battle
Abilities, attacks, weakness & resistance
Market prices (catalog API)
eBay sold comps from the Vendor Tools public catalog — tap a condition below to filter sales, or refresh to pull new data into the catalog
Catalog pricing data as of Mar 30, 2026, 6:27 PM
Guide prices and sold listings come from the Vendor Tools catalog API (eBay completed sales). Use Update prices to request a fresh pull from eBay (limited to once per 24 hours per signed-in user).
Catalog card record updated Mar 30, 2026, 6:27 PM.
No condition guide prices yet. Use Update prices to fetch eBay sold data into the catalog.
Source API: https://vendortools.net
Listed on marketplace
Vendors currently listing this card/product on our marketplace. Click through to view or purchase (purchase flow coming soon).
No marketplace listings for this card right now.
More in this set
Other cards from ホワイトフレア (White Flare)

Reshiram ex (Holofoil)#174

Hilda (Holofoil)#173

Bouffalant ex (Holofoil)#172

Hydreigon ex (Holofoil)#171

Jellicent ex (Holofoil)#170

Keldeo ex (Holofoil)#169

Reshiram ex (Holofoil)#168

Whimsicott ex (Holofoil)#167

Hilda (Holofoil)#166

Harlequin (Holofoil)#165

Bouffalant ex (Holofoil)#164

Hydreigon ex (Holofoil)#163
Comments
Share your thoughts on this card — condition, value, pull rates, etc.
to comment.
No comments yet. Be the first to share your thoughts.